AUDIENCE: Consumer, Patient, Health Care Professional, Pharmacy, Cardiology
ISSUE: Best Supplements Best Prices is recalling all lots of WAP Sensual Enhancement capsules because FDA analysis has found the product to contain undeclared sildenafil, tadalafil, and flibanserin.
Sildenafil and tadalafil are ingredients in FDA-approved prescription drugs used to treat erectile dysfunction. These undeclared ingredients may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
Flibanserin is the active ingredient in an FDA-approved prescription drug used to treat low sexual desire in women. Flibanserin can cause drowsiness, sedation, and dangerously low blood pressure and fainting, especially when combined with alcohol.
For more information about this recall, click on the red button “Read Recall” below.
BACKGROUND: WAP Sensual Enhancement UPC: 80174 00462 was marketed as a dietary supplement for sexual enhancement and was distributed nationwide in the USA via the internet on www.ebay.com.
RECOMMENDATIONS:
• Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
• Best Supplements Best Prices is notifying its customers by email and is arranging for a full refund of all recalled products. Consumers that have WAP Sensual Enhancement which is being recalled should stop using the product and dispose of it.
• Consumers with questions regarding this recall can contact Best Supplements Best Prices at eroticenhancers@gmail.com or by calling 818-856-2141.
Health care professionals, consumers and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:
• Complete and submit the report online.
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.
